Insulin Glargine vs Pembrolizumab

## Insulin Glargine vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between **Insulin Glargine** and **Pembrolizumab**.

## Mechanism of Action

**Insulin Glargine**: Long-acting insulin analogue that binds insulin receptors.

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

## Pharmacokinetics

**Half-life**: Insulin Glargine — 12-24 hours; Pembrolizumab — 26 days.

## Chemical Properties

**Type**: Insulin Glargine — Protein; Pembrolizumab — Antibody.